| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.0003 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.008 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.009 |